Utilizing a Quality of Life Tool to Examine the Presence of Fatigue in Subjects with Diabetes Mellitus

Overview

Journal J Clin Transl Endocrinol

Specialty Endocrinology

Date 2023 Nov 30

PMID 38034042

Authors

Catherine Nguyen

Henri K Parson

Jordan Pettaway

Amber Ingram

Taneisha Sears

Jason T Bard

Steven Forte

Jennifer A Wintringham

Etta Vinik

Elias S Siraj

Carolina M Casellini

Affiliations

Soon will be listed here.

Abstract

Introduction: The prevalence of fatigue in patients with diabetes mellitus (DM) can be as high as 50 %. Physical, mental, and psychosocial components of fatigue negatively impact quality of life (QOL), morbidity and mortality. Several tools have been developed to address fatigue, but none specifically for measuring fatigue in DM. The aim of this study was to assess the impact of diabetes and neuropathy on fatigue using the Norfolk QOL-Fatigue (QOL-F) survey.

Methods: 605 adult participants from were recruited (400 subjects with type 1 or type 2 DM and 205 subjects without diabetes (controls)). All subjects completed the Norfolk QOL-F. Demographics, weight, BMI, and duration of diabetes were obtained. The Norfolk QOL-F, a 35-item validated questionnaire, assesses five domains: subjective fatigue, physical and cognitive fatigue, reduced activities, impaired activities of daily living, and depression.

Results: Subjects with DM reported significantly higher fatigue total scores (52.63vs33.89, p < 0.0001) and in all five domains when compared to controls. Patients with DM with neuropathy were significantly more fatigued than those without (59.72vs27.83, p < 0.0001). Fatigue scores in patients with DM without neuropathy were similar to controls (27.83vs33.89, p = NS). In multivariate analysis, age, gender, and presence of neuropathy significantly impacted fatigue scores.

Conclusions: The Norfolk QOL-F questionnaire can potentially identify the impact of chronic diseases such as diabetes on fatigue. Assessing the different components of fatigue is important for clinicians in improving disease management and outcomes. Further investigations are needed to confirm these observations in specific cohorts with other comorbidities.

References

Ba J, Chen Y, Liu D . Fatigue in Adults with Type 2 Diabetes: A Systematic Review and Meta-analysis. West J Nurs Res. 2020; 43(2):172-181. DOI: 10.1177/0193945920938636. View

Tseng B, Gajewski B, Kluding P . Reliability, responsiveness, and validity of the visual analog fatigue scale to measure exertion fatigue in people with chronic stroke: a preliminary study. Stroke Res Treat. 2010; 2010. PMC: 2911654. DOI: 10.4061/2010/412964. View

Krupp L, Larocca N, Steinberg A . The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989; 46(10):1121-3. DOI: 10.1001/archneur.1989.00520460115022. View

Griggs S, Morris N . Fatigue Among Adults With Type 1 Diabetes Mellitus and Implications for Self-Management: An Integrative Review. Diabetes Educ. 2018; 44(4):325-339. PMC: 6372920. DOI: 10.1177/0145721718782148. View

Singh R, Kluding P . Fatigue and related factors in people with type 2 diabetes. Diabetes Educ. 2013; 39(3):320-6. DOI: 10.1177/0145721713479144. View

Galland-Decker C, Marques-Vidal P, Vollenweider P . Prevalence and factors associated with fatigue in the Lausanne middle-aged population: a population-based, cross-sectional survey. BMJ Open. 2019; 9(8):e027070. PMC: 6720133. DOI: 10.1136/bmjopen-2018-027070. View

Guessous I, Favrat B, Cornuz J, Verdon F . [Fatigue: review and systematic approach to potential causes]. Rev Med Suisse. 2007; 2(89):2725-31. View

Vinik E, Hayes R, Oglesby A, Bastyr E, Barlow P, Ford-Molvik S . The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathy. Diabetes Technol Ther. 2005; 7(3):497-508. DOI: 10.1089/dia.2005.7.497. View

Michielsen H, de Vries J, Van Heck G . Psychometric qualities of a brief self-rated fatigue measure: The Fatigue Assessment Scale. J Psychosom Res. 2003; 54(4):345-52. DOI: 10.1016/s0022-3999(02)00392-6. View

10.

Romadlon D, Hasan F, Wiratama B, Chiu H . Prevalence and risk factors of fatigue in type 1 and type 2 diabetes: A systematic review and meta-analysis. J Nurs Scholarsh. 2021; 54(5):546-553. DOI: 10.1111/jnu.12763. View

11.

Kuo H, Huang Y, Garcia A . An integrative review of fatigue in adults with type 2 diabetes mellitus: Implications for self-management and quality of life. J Clin Nurs. 2021; 31(11-12):1409-1427. DOI: 10.1111/jocn.16058. View

12.

Fritschi C, Quinn L . Fatigue in patients with diabetes: a review. J Psychosom Res. 2010; 69(1):33-41. PMC: 2905388. DOI: 10.1016/j.jpsychores.2010.01.021. View

13.

Fritschi C, Quinn L, Hacker E, Penckofer S, Wang E, Foreman M . Fatigue in women with type 2 diabetes. Diabetes Educ. 2012; 38(5):662-72. PMC: 4006984. DOI: 10.1177/0145721712450925. View

14.

Trendall J . Concept analysis: chronic fatigue. J Adv Nurs. 2000; 32(5):1126-31. DOI: 10.1046/j.1365-2648.2000.01583.x. View

15.

Vinik E, Vinik A, Neumann S, Lamichhane R, Morrison S, Colberg S . Development and Validation of the Norfolk Quality of Life Fatigue Tool (QOL-F): A New Measure of Perception of Fatigue. J Am Med Dir Assoc. 2019; 21(9):1267-1272.e2. PMC: 7295653. DOI: 10.1016/j.jamda.2019.10.021. View

16.

Dittner A, Wessely S, Brown R . The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res. 2004; 56(2):157-70. DOI: 10.1016/S0022-3999(03)00371-4. View

17.

Joli J, Buck P, Zipfel S, Stengel A . Post-COVID-19 fatigue: A systematic review. Front Psychiatry. 2022; 13:947973. PMC: 9403611. DOI: 10.3389/fpsyt.2022.947973. View

18.

Jensen O, Bernklev T, Jelsness-Jorgensen L . Fatigue in type 1 diabetes: A systematic review of Observational studies. Diabetes Res Clin Pract. 2016; 123:63-74. DOI: 10.1016/j.diabres.2016.11.002. View